near-significantp =0.056
However, a near-significant drug*time interaction was observed for baseline gamma (F(1,13)=4.41, p =0.056), non-baselined analyses were conducted, which still revealed a significant drug*time interaction for residual, active–baseline period gamma amplitude (F(1,13)=6.42, p =0.025).